Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 7, 2007 - Issue 4
Submit an article Journal homepage
1,140
Views
15
CrossRef citations to date
0
Altmetric
Editorial

Oral fluid-based rapid HIV testing: issues, challenges and research directions

Nitika Pant Pai Canadian HIV Trials Network Fellow, McGill University Health Centre, Division of Infectious Diseases and Immunodeficiency Service, Montreal Chest Institute, 3650 St Urbain Street, Montreal, Quebec, H2X 2P4, Canada. [email protected]
Pages 325-328 | Published online: 09 Jan 2014

References

  • Bass E. WHO and UNAIDS set controversial course for HIV testing. Lancet6(12), 760 (2006).
  • De Cock KM, Bunnell R, Mermin J. Unfinished business – expanding HIV testing in developing countries. N. Engl. J. Med.354, 440–442 (2006).
  • Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. Morb. Mortal. Wkly Rep.RR14, 1–17 (2006).
  • Gottfried TD, Mink RW, Phanuphak P. Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world. Expert Rev. Mol. Diagn.6, 139–144 (2006).
  • Jones JP. In the culture of now. The arrival of the OraQuick rapid HIV test. Posit. Aware15, 35–36 (2004).
  • Branson BM. FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids. AIDS Clin. Care16, 39 (2004).
  • Delaney KP, Branson BM, Uniyal A et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS20, 1655–1660 (2006).
  • Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr. Infect. Dis. Rep.8, 125–131 (2006).
  • Donovan BJ, Rublein JC, Leone PA, Pilcher CD. HIV infection: point-of-care testing. Ann. Pharmacother.38, 670–676 (2004).
  • Centers for Disease Control and Prevention. Approval of a new rapid test for HIV antibody. Morb. Mortal. Wkly Rep.51, 1051–1052 (2002).
  • Burrage J Jr. HIV rapid tests: progress, perspective, and future directions. Clin. J. Oncol. Nurs.7, 207–208 (2003).
  • Reynolds SJ, Muwonga J. OraQuick ADVANCE Rapid HIV-1/2 antibody test. Expert Rev. Mol. Diagn.4, 587–591 (2004).
  • Pant Pai N, Joshi R, Dogra S et al. Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS ONE2, e367 (2007).
  • Aaron E, Levine AB, Monahan K, Biondo CP. A rapid HIV testing program for labor and delivery in an inner-city teaching hospital. AIDS Read16, 22–24 (2006).
  • O’Connell RJ, Merritt TM, Malia JA et al. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J. Clin. Microbiol.41, 2153–2155 (2003).
  • Landrum ML, Wilson CH, Perri LP, Hannibal SL, O’Connell RJ. Usefulness of a rapid human immunodeficiency virus-1 antibody test for the management of occupational exposure to blood and body fluid. Infect. Control Hosp. Epidemiol.26, 768–774 (2005).
  • Gallo D, George JR, Fitchen JH, Goldstein AS, Hindahl MS. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group. JAMA277, 254–258 (1997).
  • Jafa K, Patel P, Mackellar DA et al. Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS ONE2, e185 (2007).
  • OraQuick® ADVANCE rapid HIV1/2 antibody test, package insert. Orasure Technologies Inc., PA, USA.
  • Pai NP, Tulsky JP, Cohan D, Colford JM Jr, Reingold AL. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis. Trop. Med. Int. Health12, 162–173 (2007).
  • Bauserman RL, Ward MA, Eldred L, Swetz A. Increasing voluntary HIV testing by offering oral tests in incarcerated populations. Am. J. Public Health91, 1226–1229 (2001).
  • Bucher JB, Thomas KM, Guzman D, Riley E, Dela Cruz N, Bangsberg DR. Community-based rapid HIV testing in homeless and marginally housed adults in San Francisco. HIV Med.8, 28–31 (2007).
  • Doyle NM, Levison JE, Gardner MO. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican–American population presenting in labor: a cost–effectiveness analysis. Am. J. Obstet. Gynecol.193, 1280–1285 (2005).

Website

  • Howerton D, Hearn TL, Onorato I, Branson B, Bock N, Kaplan J,Rayfield M; Centers for Disease Control and Prevention; US Department of Health and Human Services. Quality assurance guidelines for testing using the OraQuick Rapid HIV-1/2 Antibody test (Accessed June 2007) www.cdc.gov/hiv/topics/testing/resources/guidelines/qa_guide.htm

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.